Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion type Assertion NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_head.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion wasGeneratedBy ECO_0000203 NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_provenance.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion wasDerivedFrom befree-2016 NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_provenance.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion SIO_000772 17264302 NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_provenance.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion evidence source_evidence_literature NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_provenance.
- NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_assertion description "[In all 3 treatment phases, a glucuronosyltransferase polymorphism predicted hyperbilirubinemia (P = .017, P < .001, and P < .001) and methotrexate clearance (P = .028), which was also independently associated with hyperbilirubinemia (P = .026).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591409.RA_xilfpNZ9l3YaMnkjwVAcWPc07aU0e_1i4e8MQomjmU130_provenance.